Brain tissue oxygen monitoring for severe traumatic brain injury: the international multicentre randomised controlled BONANZA-GT study protocol
BMJ Open · 2025-10 · 15 (10) · e106962
DOI: 10.1136/bmjopen-2025-106962 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift BMJ Open, online erschienen am 02.10.2025. Verfasst von Andrew Alexander Udy und 36 weiteren Autor:innen. Beteiligte Einrichtung: Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Victoria, Australia Andrew.Udy@monash.edu. Hauptthemen laut MEDLINE: Brain, Brain Injuries, Traumatic, Oxygen. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: KCE, Health Research Council of New Zealand, Integra LiveScience Australia.
Abstract (Originalsprache)
Introduction The management of severe traumatic brain injury (sTBI) in the intensive care unit (ICU) is focused on preventing secondary brain insults, by ensuring adequate cerebral perfusion, oxygenation and substrate delivery. Despite optimisation of intracranial pressure (ICP) and cerebral perfusion pressure (CPP) using evidence-based guidelines, brain tissue hypoxia can still occur and is strongly associated with adverse functional outcomes post sTBI. Methods and analysis The Brain Oxygen Neuromonitoring in Australia and New Zealand Assessment – Global Trial (BONANZA-GT) is an international, two-arm, open-label, parallel group, randomised controlled trial comparing sTBI management incorporating early brain tissue oxygen (PbtO 2 ) monitoring and optimisation, with ICP/CPP-based management alone. A total of 860 adults admitted to participating institutions with non-penetrating sTBI and requiring insertion of an ICP monitor (as determined by the treating neurosurgeon) will be enrolled. The primary outcome is the proportion of patients with favourable neurological outcomes, as defined by a Glasgow Outcome Score-Extended (GOS-E) >4, at 6 months following injury. Key secondary outcomes include all-cause mortality at ICU discharge, hospital discharge, adverse events, as well as hospital and ICU length of stay and GOS-E at 12 months. The BONANZA-GT will determine whether a protocolised therapeutic strategy guided by continuous PbtO 2 monitoring in addition to ICP/CPP targets results in improved neurological outcomes when compared with standard care using ICP/CPP-guided management alone. Ethics and dissemination Approval has been obtained from relevant ethics boards in every jurisdiction that is participating in the trial. Inclusion of adults who lack capacity for informed consent will be governed in accordance with the legal requirements of each participating site. Study findings will be presented at scientific meetings and disseminated via peer-review publications. Trial registration number Australian and New Zealand Clinical Trials Registry (ACTRN 12619001328167).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Victoria, Australia Andrew.Udy@monash.edu.
- Department of Intensive Care and Hyperbaric Medicine, Alfred Hospital, Melbourne, Victoria, Australia.
- Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Victoria, Australia.
- Clinical Research Centre, University College Dublin, Dublin, Ireland.
- Department of Neurosurgery, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
- Department of Intensive Care, The Royal Melbourne Hospital, Parkville, Victoria, Australia.
Förderung
- KCE
- Health Research Council of New Zealand
- Integra LiveScience Australia
- Health Research Board Definitive Intervention and Feasibilty Awards
- Belgian Health Care Knowledge Centre
- Integra LifeSciences Australia
- Medical Research Future Fund
- National Health and Medical Research Council
Zitieren
APA
Udy, A. A., Jeffcote, T., Battistuzzo, C. R., Sharry, A., Adamides, A. A., Ainscough, K., Alliegro, P. V., Anstey, J., Bailey, M., Barea-Mendoza, J. A., Bellapart, J., Bouzat, P., Byrne, K., Delaney, A., Drummond, K. J., Haenggi, M., Hays, L. M., Higgins, A., Huet, O., …, & Cooper, D. J. (2025). Brain tissue oxygen monitoring for severe traumatic brain injury: the international multicentre randomised controlled BONANZA-GT study protocol. BMJ Open, 15(10), e106962. https://doi.org/10.1136/bmjopen-2025-106962
Vancouver
Udy AA, Jeffcote T, Battistuzzo CR, Sharry A, Adamides AA, Ainscough K, et al. Brain tissue oxygen monitoring for severe traumatic brain injury: the international multicentre randomised controlled BONANZA-GT study protocol. BMJ Open. 2025;15(10):e106962. doi:10.1136/bmjopen-2025-106962
BibTeX
@article{Udy2025,
author = {Udy, Andrew Alexander and Jeffcote, Toby and Battistuzzo, Camila R and Sharry, Aideen and Adamides, Alexios A and Ainscough, Kate and Alliegro, Patricia V and Anstey, James and Bailey, Michael and Barea-Mendoza, Jesús Abelardo and Bellapart, Judith and Bouzat, Pierre and Byrne, Kathleen and Delaney, Anthony and Drummond, Katharine J and Haenggi, Matthias and Hays, Leanne M and Higgins, Alisa and Huet, Olivier and Hunn, Martin K and Jakob, Stephan M and Lewis, Philip M and Lu, Kuan-Ying and Menon, David and Moore, James and Murray, Patrick T and Porter, John and Reddi, Benjamin and Rosenfeld, Jeffrey V and Taylor, Jonathon D and Trapani, Anthony and Vallance, Shirley and Wolf, Stefan and Payen, Jean-Francois and Taccone, Fabio Silvio and Nichol, Alistair and Cooper, D James},
title = {Brain tissue oxygen monitoring for severe traumatic brain injury: the international multicentre randomised controlled BONANZA-GT study protocol},
journal = {BMJ Open},
year = {2025},
volume = {15},
number = {10},
pages = {e106962},
doi = {10.1136/bmjopen-2025-106962}
}
EUVIMED